
View larger version (68K):
[in a new window]
|
Fig. 7. Msx1 expression at different stages of chick development from E2
to E8.5 (A-F), and its regulation after the graft of Noggin (G,H) or Shh (I)
cell aggregates, and after treatment with cyclopamine (J-N). (A,B) Dorsal view
(A) and transversal section (B) at late stage HH13 posterior to the level of
the last somite formed (double arrow in A). Msx1 is expressed in the
dorsal neural tube (nt), in the distal somatopleural mesoderm (dsm) and weakly
in the extra-embryonic area (ee). (C-F) Msx1 expression on the
lateral side at E3 (C) and E4.5 (D), and on the ventral side at E6.5 (E) and
E8.5 (F). There is progressive restriction of the domain of Msx1
expression from E4.5 to E8.5 to the midventral apterium (mva), as well as
expression in the amnion forming the umbilical cord (fu) at early stages, or
later, the umbilical cord wall (u). (G,H) Msx1 expression is
downregulated 24 hours (G) and 72 hours (H) after grafting of Noggin cells
(asterisk). (I) Transverse section at E3 of an embryo showing that
Msx1 expression is downregulated over the Shh cell aggregate
(asterisk). (J-N) The proximal limit of the Msx1 expression domain
(arrowhead, dotted line) is extended in the proximal somatopleure 72 hours
(J-L) after the inhibition of Shh signaling mediated by a treatment with
cyclopamine, in contrast to a control (M,N) embryo. (K) Close-up of the embryo
shown in J. The domain of expression is larger in the treated embryo (K,L)
than in the control (M,N). The extent of Msx1 expression can be
determined by reference to the kidney (k) and to the extremity of the coelom
(*). ant, anterior; lb, limb bud; post, posterior; ps, presomitic
mesoderm; psm, proximal somatopleural mesoderm; so (white dotted line),
somite; sp, splanchnopleure. Scale bars: 100 µm in A,I; 60 µm in B; 75
µm in C,G; 500 µm in D,H,J; 700 µm in E; 750 µm in F; 110 µm in
K,L; 100 µm in M,N.
|